(Q38268809)

English

Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetes

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 September 2017

0 references

Synergism between metformin and statins in modifying the risk of biochemical recurrence following radical prostatectomy in men with diabetes (English)

1 reference

Europe PubMed Central

1 September 2017

1 reference

based on heuristic

inferred from title

author name string

M R Danzig

1

1 reference

Europe PubMed Central

1 September 2017

S Kotamarti

2

1 reference

Europe PubMed Central

1 September 2017

R A Ghandour

3

1 reference

Europe PubMed Central

1 September 2017

M B Rothberg

4

1 reference

Europe PubMed Central

1 September 2017

B P Dubow

5

1 reference

Europe PubMed Central

1 September 2017

M C Benson

6

1 reference

Europe PubMed Central

1 September 2017

K K Badani

7

1 reference

Europe PubMed Central

1 September 2017

J M McKiernan

8

1 reference

Europe PubMed Central

1 September 2017

publication date

18 November 2014

1 reference

Europe PubMed Central

1 September 2017

Prostate Cancer and Prostatic Diseases

1 reference

Europe PubMed Central

1 September 2017

18

1 reference

Europe PubMed Central

1 September 2017

1

1 reference

Europe PubMed Central

1 September 2017

63-68

1 reference

Europe PubMed Central

1 September 2017

https://scigraph.springernature.com/pub.10.1038/pcan.2014.47

0 references

Cancer statistics, 2014

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Time trends and local variation in primary treatment of localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Statins and prostate cancer: molecular and clinical aspects

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Statins and cancer prevention

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Association between statins and prostate tumor inflammatory infiltrate in men undergoing radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Metabolic alterations and targeted therapies in prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Metformin targets c-MYC oncogene to prevent prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Statin use and risk of prostate cancer: a meta-analysis of observational studies

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Statin medication use and the risk of biochemical recurrence after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Statin use and reduced cancer-related mortality

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Association of metformin use with cancer incidence and mortality: a meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

The time is ripe for a randomized trial of metformin in clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Statin use as a moderator of metformin effect on risk for prostate cancer among type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

The influence of statin medications on prostate-specific antigen levels

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

The influence of antidiabetic medications on the development and progression of prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Immortal time bias in pharmaco-epidemiology

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia.

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

AMP-activated kinase (AMPK)-generated signals in malignant melanoma cell growth and survival

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

21 January 2018

The Long-Term Clinical Impact of Biochemical Recurrence of Prostate Cancer 5 or More Years After Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

31 March 2020

Pathological characteristics, biochemical recurrence and functional outcome in radical prostatectomy patients on statin therapy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

31 March 2020

Effect of statin use on biochemical outcome following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1038%2FPCAN.2014.47

31 March 2020

The statins as anticancer agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/25403419

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/PCAN.2014.47

1 reference

Europe PubMed Central

1 September 2017

release_dp5k4d4enbcrncc3ulzhefk7ga

1 reference

https://api.fatcat.wiki/v0/release/dp5k4d4enbcrncc3ulzhefk7ga

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

1 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38268809&oldid=1978020701"